Singapore markets closed

ABBV Jan 2025 100.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.5600+0.0600 (+12.00%)
As of 10:04AM EDT. Market open.
Full screen
Previous close0.5000
Open0.5300
Bid0.4600
Ask0.7000
Strike100.00
Expiry date2025-01-17
Day's range0.5300 - 0.5600
Contract rangeN/A
Volume3
Open interest1.76k
  • Yahoo Finance Video

    PCE reading, Microsoft, Alphabet jump on earnings: Yahoo Finance

    Investors are digesting the Fed's preferred inflation measure after the release of the Personal Consumption Expenditures (PCE) index.Big Tech is coming to the rescue on Wall Street. Microsoft (MSFT) and Alphabet (GOOGL, GOOG) are jumping following their latest earning reports. Both companies topped expectations and were helped by their AI businesses. The news comes after a rough day for stocks, with a weaker-than-expected GDP report and earnings from companies such as Meta (META), sending markets deep in the red. Today, we will hear from big names, including ExxonMobil (XOM), Chevron (CVX), Colgate-Palmolive (CL), and AbbVie (ABBV). Yahoo Finance trending tickers include Intel (INTC), Snap (SNAP), and Roku (ROKU). Key guests include:9 a.m. ET - Brian Rose -UBS Global Wealth Management Senior US Economist10:40 a.m. ET - Chris Peterson, Newell Brands CEO11:20 a.m. ET - Patrick Gelsinger, Intel CEO

  • GuruFocus.com

    AbbVie Inc (ABBV) Q1 2024 Earnings: Adjusted EPS Tops Estimates Despite Revenue Challenges

    Comprehensive Analysis of AbbVie's Latest Financial Performance

  • Zacks

    AbbVie (ABBV) Beats Q1 Earnings and Revenue Estimates

    AbbVie (ABBV) delivered earnings and revenue surprises of 2.21% and 2.65%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?